• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Application of fragment growing and fragment linking to the discovery of inhibitors of Mycobacterium tuberculosis pantothenate synthetase.

作者信息

Hung Alvin W, Silvestre H Leonardo, Wen Shijun, Ciulli Alessio, Blundell Tom L, Abell Chris

机构信息

Department of Chemistry, University of Cambridge, UK.

出版信息

Angew Chem Int Ed Engl. 2009;48(45):8452-6. doi: 10.1002/anie.200903821.

DOI:10.1002/anie.200903821
PMID:19780086
Abstract
摘要

相似文献

1
Application of fragment growing and fragment linking to the discovery of inhibitors of Mycobacterium tuberculosis pantothenate synthetase.片段生长和片段连接在结核分枝杆菌泛酸合成酶抑制剂发现中的应用。
Angew Chem Int Ed Engl. 2009;48(45):8452-6. doi: 10.1002/anie.200903821.
2
Inhibition of Mycobacterium tuberculosis pantothenate synthetase by analogues of the reaction intermediate.反应中间体类似物对结核分枝杆菌泛酸合成酶的抑制作用。
Chembiochem. 2008 Nov 3;9(16):2606-11. doi: 10.1002/cbic.200800437.
3
A novel inhibitor of Mycobacterium tuberculosis pantothenate synthetase.一种新型结核分枝杆菌泛酸合成酶抑制剂。
J Biomol Screen. 2007 Feb;12(1):100-5. doi: 10.1177/1087057106296484. Epub 2006 Dec 14.
4
Optimization of Inhibitors of Mycobacterium tuberculosis Pantothenate Synthetase Based on Group Efficiency Analysis.基于基团效率分析的结核分枝杆菌泛酸合成酶抑制剂优化
ChemMedChem. 2016 Jan 5;11(1):38-42. doi: 10.1002/cmdc.201500414. Epub 2015 Oct 21.
5
Optimization of the interligand Overhauser effect for fragment linking: application to inhibitor discovery against Mycobacterium tuberculosis pantothenate synthetase.优化配体间的 Overhauser 效应进行片段连接：在抗结核分枝杆菌泛酸合成酶抑制剂发现中的应用。
J Am Chem Soc. 2010 Apr 7;132(13):4544-5. doi: 10.1021/ja100595u.
6
A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition.基于放线菌素 D 抑制机制的新型结核分枝杆菌泛酸合成酶抑制剂的发现。
Bioorg Med Chem Lett. 2011 Jul 1;21(13):3943-6. doi: 10.1016/j.bmcl.2011.05.021. Epub 2011 May 14.
7
Binding of pyrazole-based inhibitors to Mycobacterium tuberculosis pantothenate synthetase: docking and MM-GB(PB)SA analysis.基于吡唑的抑制剂与结核分枝杆菌泛酸合成酶的结合：对接和MM-GB（PB）SA分析。
Mol Biosyst. 2014 Feb;10(2):223-39. doi: 10.1039/c3mb70449a.
8
Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.新型基于四氢噻吩并[2,3-c]吡啶-3-甲酰胺的结核分枝杆菌泛酸合成酶抑制剂的开发：源于已知抗分枝杆菌先导化合物的分子杂交
Bioorg Med Chem. 2014 Mar 15;22(6):1938-47. doi: 10.1016/j.bmc.2014.01.030. Epub 2014 Feb 6.
9
5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs.5-叔丁基-N-吡唑-4-基-4,5,6,7-四氢苯并[d]异恶唑-3-甲酰胺衍生物作为结核分枝杆菌泛酸合成酶的新型强效抑制剂：开启新型抗结核药物的探索
J Med Chem. 2008 Apr 10;51(7):1999-2002. doi: 10.1021/jm701372r. Epub 2008 Mar 13.
10
A high-throughput screen against pantothenate synthetase (PanC) identifies 3-biphenyl-4-cyanopyrrole-2-carboxylic acids as a new class of inhibitor with activity against Mycobacterium tuberculosis.高通量筛选对泛酸合成酶（PanC）的研究发现，3-联苯-4-氰基吡咯-2-羧酸是一类具有抗结核分枝杆菌活性的新型抑制剂。
PLoS One. 2013 Nov 7;8(11):e72786. doi: 10.1371/journal.pone.0072786. eCollection 2013.

引用本文的文献

1
Unlocking GPCR-ligand interactions: Measuring binding affinities with thermal shift assay.揭示G蛋白偶联受体（GPCR）与配体的相互作用：利用热位移测定法测量结合亲和力。
Protein Sci. 2025 May;34(5):e70120. doi: 10.1002/pro.70120.
2
Trends in the research and development of peptide drug conjugates: artificial intelligence aided design.肽药物偶联物的研发趋势：人工智能辅助设计
Front Pharmacol. 2025 Feb 27;16:1553853. doi: 10.3389/fphar.2025.1553853. eCollection 2025.
3
Expanding FTMap for Fragment-Based Identification of Pharmacophore Regions in Ligand Binding Sites.
扩展 FTMap 以基于片段的方法鉴定配体结合位点中的药效基团区域。
J Chem Inf Model. 2024 Mar 25;64(6):2084-2100. doi: 10.1021/acs.jcim.3c01969. Epub 2024 Mar 8.
4
Medicinal Chemistry Strategies for the Modification of Bioactive Natural Products.药用化学策略在生物活性天然产物修饰中的应用。
Molecules. 2024 Feb 2;29(3):689. doi: 10.3390/molecules29030689.
5
: Pathogenesis and therapeutic targets.发病机制与治疗靶点。
MedComm (2020). 2023 Sep 4;4(5):e353. doi: 10.1002/mco2.353. eCollection 2023 Oct.
6
The pathogenic mechanism of Mycobacterium tuberculosis: implication for new drug development.结核分枝杆菌的致病机制：对新药研发的启示
Mol Biomed. 2022 Dec 22;3(1):48. doi: 10.1186/s43556-022-00106-y.
7
Fragment-Based Drug Discovery against Mycobacteria: The Success and Challenges.基于片段的抗分枝杆菌药物发现：成功与挑战。
Int J Mol Sci. 2022 Sep 14;23(18):10669. doi: 10.3390/ijms231810669.
8
Discovery and Structural Characterization of Small Molecule Binders of the Human CTLH E3 Ligase Subunit GID4.发现并结构表征人 CTLH E3 连接酶亚基 GID4 的小分子结合物。
J Med Chem. 2022 Oct 13;65(19):12725-12746. doi: 10.1021/acs.jmedchem.2c00509. Epub 2022 Sep 18.
9
Design, synthesis and biological evaluation of benzo-[]-imidazo-[2,1-]-thiazole and imidazo-[2,1-]-thiazole carboxamide triazole derivatives as antimycobacterial agents.苯并[]咪唑并[2,1-]噻唑和咪唑并[2,1-]噻唑甲酰胺三唑衍生物作为抗分枝杆菌药物的设计、合成及生物学评价
RSC Adv. 2022 Aug 10;12(35):22385-22401. doi: 10.1039/d2ra03318f.
10
Indole: A promising scaffold for the discovery and development of potential anti-tubercular agents.吲哚：用于发现和开发潜在抗结核药物的一种有前景的骨架。
Curr Res Pharmacol Drug Discov. 2022 Jul 16;3:100119. doi: 10.1016/j.crphar.2022.100119. eCollection 2022.